Testing Hypotheses About an Identified Treatment When There are Multiple Endpoints
From MaRDI portal
Publication:4031063
DOI10.2307/2290221zbMATH Open0781.62078OpenAlexW4252444374MaRDI QIDQ4031063FDOQ4031063
Authors: Eugene Laska, Dei-In Tang, Morris Meisner 
Publication date: 1 April 1993
Full work available at URL: https://doi.org/10.2307/2290221
Recommendations
- Testing Whether an Identified Treatment Is Best
- Improved Tests for Comparing Treatments Against a Control and Other One-Sided Problems
- One-sided tests in clinical trials with multiple endpoints
- Directional multivariate tests rejecting null and negative effects in all variables
- The use of an identity in Anderson for multivariate multiple testing
powerlikelihood ratio testmultivariate normalBonferroni inequalityadmissibleunknown covariance matrixmin testcombination treatmentcomposite alternative hypothesesidentified treatmentuniformly best
Cited In (12)
- On O'Brien's OLS and GLS tests for multiple endpoints
- More powerful tests for the sign testing problem
- The emperor's new tests. (With comments and a rejoinder).
- Testing Whether an Identified Treatment Is Best
- Improved Tests for Comparing Treatments Against a Control and Other One-Sided Problems
- A Bayesian Group Sequential Approach for Multiple Endpoints
- The use of an identity in Anderson for multivariate multiple testing
- A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials
- An appraisal of some aspects of statistical inference under inequality constraints
- Procedures for testing multiple endpoints in clinical trials: an overview
- Supplementary test procedures for overall treatment effect
- One-sided tests in clinical trials with multiple endpoints
This page was built for publication: Testing Hypotheses About an Identified Treatment When There are Multiple Endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4031063)
